Nifty’s short-covering rally may extend as Metal and Healthcare flash bullish setups; watch Torrent Pharma, Apollo and key levels Monday.
Chronic therapies are growing faster than the broader pharma market. Discover how four companies are using acquisitions, innovation, and portfolio…
Corporate India is set for a packed Q4FY26 earnings week with 680 companies announcing results. Key names include ITC, BPCL,…
Markets surged, but not on fresh buying: Ambit sees a short-covering rally as rollover data reveals selective bets in pharma,…
Motilal Oswal is reshaping its FY26 strategy—betting on SBI, Jio Financial and domestic growth plays as crude risks and global…
Monday watchlist, March 30: Track Sun Pharma, HDFC Bank and ICICI as market volatility surges; review key stock setups and…
Super investor and a Warren Buffett of India, Mukul Agarwal, has just added two new stocks to his portfolio sending…
From generics to branded drugs, Jefferies’ latest pharma calls spotlight Alkem, Lupin, Sun Pharma, Torrent, and Zydus as India’s key…
Seasonality suggests November softness and December strength, yet select Pharma counters consistently outperform. Three stocks offering the favourable risk-reward from…
Jefferies names M&M, TVS Motor, Jindal Stainless, Sun Pharma, and Mankind Pharma as top September buys—see why these stocks could…
Stocks to watch today, August 01: GIFT Nifty indicates a lower start for domestic indices. Here are the top stocks…
Trump’s new tariffs spark uncertainty for India’s pharma exports and stocks; check out how the sector is reacting and what…
Track midday stock movers like HCL Tech, Tata Steel, Mankind Pharma, and Vedanta; review key market catalysts and analyst insights…
On Wednesday, Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin…
Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure.
The integration of BSV is on track, with focus on mandate brands, improving productivity and adopting best practices to ensure…
During the quarter, we have launched 1 new product in US taking the total launched products to 42.
According to the company’s statement, Mankind Pharma may consider to retire, a portion of the debt through a potential equity…